Long COVID History Taking OSCE — NICE Criteria, Symptom Clusters, and Management

Why This Station Is Tested

Long COVID (post-COVID-19 condition) affects an estimated 1.8 million people in the UK (ONS data 2023) and has become a high-yield OSCE topic as it requires history-taking skills, understanding of NICE guidance, management planning, and compassionate communication with patients who may have been disbelieved. Medical schools include long COVID in internal medicine, primary care, and communication skills circuits.

NICE Diagnostic Criteria

NICE guideline NG188 (updated 2022) defines three phases of post-COVID illness:

Long COVID is a clinical diagnosis — it does not require proof of prior COVID-19 infection (many patients were tested during a period of limited testing access). A positive PCR, lateral flow test, or serology supports the diagnosis but is not required.

Opening the History

Use an open question: "Can you tell me about what's been happening with your health since you had COVID-19?" Allow the patient to describe their experience freely — many patients feel dismissed and the therapeutic value of being heard is itself clinically important. Acknowledge: "It sounds like you've been through a really difficult time."

Symptom Clusters — Systematic Assessment

Long COVID presents with more than 200 reported symptoms. In the OSCE, assess systematically across the key symptom clusters:

1. Fatigue (Most Common — Reported by 74%)

• Onset relative to acute infection, fluctuating or persistent?
• Post-exertional malaise (PEM) — key feature: worsening of symptoms following physical or cognitive exertion, typically with a 12–48-hour delay. "Do you notice your symptoms getting worse after you push yourself physically or mentally, perhaps the next day or two days later?"
• Impact on activities of daily living — use MRC breathlessness scale or DASI for function
• Distinguish from depression-related fatigue (though comorbid depression is common)

2. Breathlessness and Respiratory Symptoms

• Dyspnoea on exertion — MRC Dyspnoea Scale (1–5)
• Cough — persistent dry cough
• Chest tightness, chest pain
• Assess exercise tolerance: "How far can you walk on the flat before stopping for breath? Can you climb stairs?"
• Consider sequelae: pulmonary fibrosis (ILD post-COVID), pulmonary embolism (PE — was patient hospitalised acutely?)

3. Cognitive Symptoms — "Brain Fog"

• Concentration difficulties: "Do you find it hard to concentrate or follow a conversation?"
• Memory problems: short-term memory loss, word-finding difficulties
• Processing speed: difficulty multitasking, feeling mentally slowed
• Impact on work, reading, driving

4. Cardiovascular Symptoms

• Palpitations — document frequency, duration, triggers
• Postural symptoms (POTS — Postural Orthostatic Tachycardia Syndrome): dizziness, presyncope on standing, tachycardia; a specific autonomic condition seen post-COVID
• Chest pain — characterise carefully

5. Pain

• Headache: tension-type, new onset, daily persistent
• Myalgia (muscle pain) — diffuse, often fluctuating
• Arthralgia (joint pain) — migratory, without swelling
• Neuropathic symptoms: tingling, burning

6. Other Common Symptoms

• Anosmia/parosmia (loss of or altered smell — may persist months)
• Dysgeusia (altered taste)
• Sleep disturbance (insomnia, non-restorative sleep)
• Mental health: anxiety, depression, PTSD symptoms
• Skin: hair loss (telogen effluvium — diffuse, 3 months post-illness)

Timeline and Fluctuation

Ask: "Do your symptoms fluctuate? Are there good days and bad days?" The relapsing-remitting nature of long COVID with PEM is characteristic. Establish the trajectory — improving, static, or worsening?

Impact Assessment

Use validated tools: PCFS (Post-COVID Functional Status Scale), MRC Dyspnoea Scale, PHQ-9 and GAD-7 (depression and anxiety).

Relevant Past Medical History

Prior COVID-19 hospitalisation (required oxygen, ITU?), pre-existing conditions (asthma, heart disease — may confound symptoms), vaccination status (vaccination reduces long COVID risk), mental health history.

Investigations — NICE NG188

NICE recommends offering investigation to exclude underlying conditions and treatable causes:

Note: many investigations in long COVID are normal — a normal result does not invalidate the diagnosis.

Management — NICE NG188 and NHS Long COVID Services

Frequently Asked Questions

"What are the NICE diagnostic criteria for long COVID and how is the diagnosis made?"

NICE guideline NG188 (updated 2022) defines post-COVID-19 condition (long COVID) as signs and symptoms that develop during or after an infection consistent with COVID-19, continue for more than 12 weeks, and are not explained by an alternative diagnosis. The diagnosis is clinical — it does not require laboratory confirmation of prior COVID-19 infection, which is important because many patients became ill when testing was not widely available. The condition may include a variety of symptoms that fluctuate and change over time, and can affect any organ system. The 12-week threshold distinguishes long COVID from "ongoing symptomatic COVID-19" (4–12 weeks). A key feature is that symptoms may be absent at rest and triggered by exertion — post-exertional malaise. In the OSCE, stating the NICE definition clearly and noting it is a clinical diagnosis (not requiring proof of prior infection) demonstrates guideline knowledge that examiners reward.

"What is post-exertional malaise and why is it the most clinically important feature of long COVID?"

Post-exertional malaise (PEM) is the worsening of symptoms following physical or cognitive exertion, with a characteristic delayed onset of 12–48 hours after the triggering activity. It is clinically important because it explains the relapsing nature of long COVID (patients overexert on a good day and then crash), because it guides management (pacing and energy management rather than push-through exercise), and because it distinguishes long COVID fatigue from simple deconditioning or depression-related fatigue, where graduated exercise would typically be helpful. Asking specifically about PEM is a mark-scheme point: "Do you notice your symptoms becoming significantly worse after you do physical activity or mental work, even mild activity — perhaps the next day or two days later?" Recognising PEM is the basis for recommending energy management (pacing) over graded exercise therapy — NICE removed GET as a recommended treatment for post-COVID fatigue in 2021 following evidence of harm in PEM-type conditions.

"What is POTS and how does it present in the context of long COVID?"

Postural Orthostatic Tachycardia Syndrome (POTS) is an autonomic dysfunction characterised by an excessive heart rate increase on standing (≥30 beats per minute within 10 minutes of standing, or ≥40 bpm in those aged 12–19) without a significant drop in blood pressure, accompanied by symptoms of orthostatic intolerance. In long COVID, POTS is increasingly recognised as a significant cause of symptoms and may be caused by immune-mediated autonomic dysfunction or small fibre neuropathy post-COVID. Presenting symptoms: dizziness and presyncope on standing, palpitations, fatigue that is worse when upright, headache, brain fog, and blurred vision — all relieved by lying down. Bedside assessment: measure lying and standing heart rate and blood pressure (active stand test or NASA lean test — 10 minutes standing) — a sustained heart rate rise of ≥30 bpm without BP drop is suggestive. Formal diagnosis requires tilt-table testing. Management: increased salt and fluid intake, compression garments, avoidance of prolonged standing, and in refractory cases, beta-blockers (propranolol), fludrocortisone, or ivabradine.

"What investigations should be arranged for a patient presenting with long COVID symptoms?"

NICE NG188 recommends a structured investigation approach to exclude underlying conditions and identify treatable pathology. First-line bloods: FBC (anaemia, lymphopenia), CRP and ESR (ongoing inflammation), U&E and eGFR (renal impairment post-COVID AKI), LFTs, TFTs (thyroid disease can mimic fatigue, cognitive symptoms), HbA1c (new-onset diabetes post-COVID), ferritin (iron deficiency — common cause of fatigue), B12 and folate (deficiency — neurological symptoms), Vitamin D (deficiency — fatigue, musculoskeletal pain). Targeted investigations: ECG (arrhythmia, myocarditis screen), chest X-ray (post-COVID pulmonary changes), spirometry (persistent breathlessness), D-dimer or CTPA (if clinical suspicion of PE — COVID is pro-thrombotic), 24-hour Holter monitor (palpitations, POTS screening), active stand test (POTS). Note that many investigations are normal in long COVID — a normal result validates the clinical diagnosis, it does not negate it. The absence of organic findings means a patient's symptoms should be managed, not dismissed.

"How should you communicate with a patient who feels they have not been believed about their long COVID symptoms?"

Many long COVID patients have experienced disbelief, dismissal, or attribution of symptoms to anxiety or malingering from healthcare professionals and employers. Therapeutic communication begins with explicit validation: "I want you to know that I take everything you're telling me seriously — these are real symptoms that affect many people after COVID-19, and the research on this condition is growing rapidly." Avoid language that implies doubt ("I can't find anything wrong"), and instead frame normal investigations as information: "The good news is that we haven't found any serious underlying damage, which means we can focus on the most effective strategies to help you manage and recover." Use person-centred language, ask about the impact on the patient's life, acknowledge the frustration of a prolonged and often fluctuating illness, and engage shared decision-making for investigations and management. This approach — validating, normalising, investigating appropriately, and planning together — is both what the OSCE mark scheme rewards and what evidence shows improves patient outcomes in functional illness.

"What are the key management principles for long COVID according to current NICE guidance?"

NICE NG188 (2022) recommends a holistic, MDT approach to long COVID management. The key principles are: (1) Energy management and pacing — patients with post-exertional malaise should use activity management (Heart Rate Monitoring, pacing apps, energy envelopes) to avoid boom-and-bust cycles; graded exercise therapy (GET) should NOT be recommended as the sole treatment for fatigue where PEM is present; (2) Symptom-specific management — breathlessness (breathing physiotherapy), cognitive symptoms (cognitive rehabilitation, occupational therapy), mood (IAPT referral, CBT, antidepressants if clinical depression), POTS (increased salt/fluid, compression, beta-blockers); (3) Investigation and exclusion of treatable conditions — as above; (4) Referral to specialist long COVID services — NHS England commissioned long COVID assessment clinics providing MDT care; (5) Return-to-work planning — phased return, occupational health, sick notes; (6) Social support — PIP (Personal Independence Payment) assessment if function significantly impaired. Vaccination reduces the risk of developing long COVID — mention this when discussing prevention. Regular follow-up and review of the management plan are emphasised.

Related guides: Tiredness and Fatigue History OSCE · Respiratory Examination OSCE · Cough History OSCE · Depression and Anxiety History OSCE · Peak Flow and Spirometry OSCE